University of Florida Research Foundation;AbbVie, Inc.
发明人:
Soren Nielsen,Thomas Engelbrecht Nordkilk Jonassen,Samina Khan,Mark T. Houser,Ib Bo Lumholtz,Michael Beckert,Thomas Beaver
申请号：
US13844131
公开号：
US20140100165A1
申请日:
2013.03.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
